Atairos-Orogen Holdings, LLC

SEC source: 0000950103-25-016153 · dp238732_4-oellc.xml · nonDerivative · entry 1

Orogen Echo LLC · CIK 0001754751 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

F1 · kind: On December 15, 2025, Issuer repurchased 1,551,970 shares of the Company's common stock from Orogen Echo LLC ("OE") pursuant to the terms of the Stock Purchase Agreement by and between the Issuer and OE, dated December 15, 2025.

F2 · shares: The reported number of securities has been adjusted to reflect the impact of the 5-for-1 forward stock split effective August 1, 2023.

F2 · balance_after: The reported number of securities has been adjusted to reflect the impact of the 5-for-1 forward stock split effective August 1, 2023.

F3 · ownership.nature: Vikram Pandit serves on the Board and is the Chairman and Chief Executive Officer of OE. Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC, which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the Issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-25-007672 · dp230429_4-pandit.xml · derivative · entry 1

PANDIT VIKRAM S · CIK 0001183417 · Director

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 73,085

Underlying: Common Stock, par value $0.001 per shar · 7,146 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock upon settlement.

F2 · derivative.exercise_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2025 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F2 · derivative.expiration_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2025 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F3 · ownership.nature: Mr. Pandit serves on the Board and is the Chairman and Chief Executive Officer of Orogen Echo LLC ("OE"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC, which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-24-008709 · dp213232_4-pandit.xml · derivative · entry 1

PANDIT VIKRAM S · CIK 0001183417 · Director

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · SEE FOOTNOTES

Disclosed balance after: 65,939

Underlying: Common Stock, par value $0.001 per share · 10,344 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock upon settlement.

F2 · derivative.exercise_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F2 · derivative.expiration_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F3 · balance_after: The reported number of securities has been adjusted to reflect the impact of the 5-for-1 forward stock split effective August 1, 2023.

F4 · ownership.nature: Mr. Pandit serves on the Board and is the Chairman and Chief Executive Officer of Orogen Echo LLC ("OE"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC, which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F5 · ownership.nature: Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-23-009119 · dp195624_4-pandit.xml · derivative · entry 1

PANDIT VIKRAM S · CIK 0001183417 · Director

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote:

Disclosed balance after: 10,376

Underlying: Common Stock, par value $0.001 per share · 1,847 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock upon settlement.

F2 · derivative.exercise_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F2 · derivative.expiration_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F3 · ownership.nature: Mr. Pandit serves on the Board and is the Chairman and Chief Executive Officer of Orogen Echo LLC ("OE"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC, which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-23-017844 · dp204260_4a-pandit.xml · derivative · entry 1

PANDIT VIKRAM S · CIK 0001183417 · Director

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 11,119

Underlying: Common Stock, par value $0.001 per share · 1,847 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock upon settlement.

F2 · derivative.exercise_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F2 · derivative.expiration_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F3 · ownership.nature: Mr. Pandit serves on the Board and is the Chairman and Chief Executive Officer of Orogen Echo LLC ("OE"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC, which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-22-011067 · dp175748_4-pandit.xml · derivative · entry 1

PANDIT VIKRAM S · CIK 0001183417 · Director

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 8,529

Underlying: Common Stock, par value $0.001 per share · 1,411 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock upon settlement.

F2 · derivative.exercise_date: The restricted stock units, which were granted in connection with Mr. Pandit's appointment as Chairman of the Board of Directors of the issuer (the "Board"), vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F2 · derivative.expiration_date: The restricted stock units, which were granted in connection with Mr. Pandit's appointment as Chairman of the Board of Directors of the issuer (the "Board"), vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F3 · ownership.nature: Mr. Pandit serves on the Board and is the Chairman and Chief Executive Officer of Orogen Echo LLC ("OE"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC, which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-22-011318 · dp176008_4-pandit.xml · derivative · entry 1

PANDIT VIKRAM S · CIK 0001183417 · Director

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 9,272

Underlying: Common Stock, par value $0.001 per share · 2,154 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock upon settlement.

F2 · derivative.exercise_date: The restricted stock units, which were granted in connection with Mr. Pandit's appointment as Chairman of the Board of Directors of the issuer (the "Board"), vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F2 · derivative.expiration_date: The restricted stock units, which were granted in connection with Mr. Pandit's appointment as Chairman of the Board of Directors of the issuer (the "Board"), vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F3 · ownership.nature: Mr. Pandit serves on the Board and is the Chairman and Chief Executive Officer of Orogen Echo LLC ("OE"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC, which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-22-000144 · dp164736_4-pandit.xml · derivative · entry 1

PANDIT VIKRAM S · CIK 0001183417 · Director

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 7,118

Underlying: Common Stock, par value $0.001 per share · 340 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock upon settlement.

F2 · derivative.exercise_date: The restricted stock units, which were granted in connection with Mr. Pandit's appointment as Chairman of the Board of Directors of the issuer (the "Board"), vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F2 · derivative.expiration_date: The restricted stock units, which were granted in connection with Mr. Pandit's appointment as Chairman of the Board of Directors of the issuer (the "Board"), vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F3 · ownership.nature: Mr. Pandit serves on the Board and is the Chairman and Chief Executive Officer of Orogen Echo LLC ("OE"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC, which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-21-015509 · dp158133_4-orogen.xml · derivative · entry 3

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

Underlying: Common Stock · Not disclosed shares

Expires not disclosed

F2 · derivative.exercise_price: Under the terms of the 2024 Notes, upon conversion of the 2024 Notes, the Issuer was required to deliver, at the Issuer's election, cash, shares of Common Stock, or a combination of cash and shares of Common Stock. The 2024 Notes had an initial conversion rate of 13.3333 shares of Common Stock per $1,000 principal amount of the 2024 Notes, which was the equivalent of an initial conversion price of approximately $75 per share of Common Stock. The initial conversion rate was subject to adjustment from time to time in accordance with the terms of an indenture, dated as of October 4, 2018, by and between the Issuer and Citibank, N.A., as trustee.

F1 · kind: Reflects an exchange of $150 million aggregate principal amount of the Issuer's 3.50% Convertible Senior Notes due October 1, 2024 (the "2024 Notes") held by the Reporting Persons for (i) a cash payment of $200 million plus accrued and unpaid interest on the reported securities through, and including, August 26, 2021 and (ii) 310,394 shares of common stock of the Issuer, par value $0.001 per share ("Common Stock"), which share amount was calculated using a 20-day volume weighted average price ending on, and including, August 26, 2021.

F1 · shares: Reflects an exchange of $150 million aggregate principal amount of the Issuer's 3.50% Convertible Senior Notes due October 1, 2024 (the "2024 Notes") held by the Reporting Persons for (i) a cash payment of $200 million plus accrued and unpaid interest on the reported securities through, and including, August 26, 2021 and (ii) 310,394 shares of common stock of the Issuer, par value $0.001 per share ("Common Stock"), which share amount was calculated using a 20-day volume weighted average price ending on, and including, August 26, 2021.

F5 · derivative.exercise_date: The reported securities were convertible at any time prior to the close of business on the scheduled trading day immediately preceding October 1, 2024, subject to earlier conversion or redemption in accordance with their terms.

F5 · derivative.expiration_date: The reported securities were convertible at any time prior to the close of business on the scheduled trading day immediately preceding October 1, 2024, subject to earlier conversion or redemption in accordance with their terms.

F2 · derivative.underlying_shares: Under the terms of the 2024 Notes, upon conversion of the 2024 Notes, the Issuer was required to deliver, at the Issuer's election, cash, shares of Common Stock, or a combination of cash and shares of Common Stock. The 2024 Notes had an initial conversion rate of 13.3333 shares of Common Stock per $1,000 principal amount of the 2024 Notes, which was the equivalent of an initial conversion price of approximately $75 per share of Common Stock. The initial conversion rate was subject to adjustment from time to time in accordance with the terms of an indenture, dated as of October 4, 2018, by and between the Issuer and Citibank, N.A., as trustee.

F3 · ownership.nature: Orogen Echo LLC ("OE") directly owns the reported securities. The Orogen Group LLC ("Orogen") is the sole member of OE and Vikram S. Pandit ("Mr. Pandit") is the Chairman and Chief Executive Officer of Orogen and serves on the board of directors of ExlService Holdings, Inc. (the "Issuer"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of Orogen. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the Reporting Persons, other than Mr. Pandit, is acting as a director by deputization of the Issuer with respect to Mr. Pandit's membership on the board of directors of the Issuer. Each of the Reporting Persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-21-015509 · dp158133_4-orogen.xml · derivative · entry 2

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,689,606

Underlying: Common Stock · Not disclosed shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Under the terms of the 2024 Notes, upon conversion of the 2024 Notes, the Issuer was required to deliver, at the Issuer's election, cash, shares of Common Stock, or a combination of cash and shares of Common Stock. The 2024 Notes had an initial conversion rate of 13.3333 shares of Common Stock per $1,000 principal amount of the 2024 Notes, which was the equivalent of an initial conversion price of approximately $75 per share of Common Stock. The initial conversion rate was subject to adjustment from time to time in accordance with the terms of an indenture, dated as of October 4, 2018, by and between the Issuer and Citibank, N.A., as trustee.

F1 · kind: Reflects an exchange of $150 million aggregate principal amount of the Issuer's 3.50% Convertible Senior Notes due October 1, 2024 (the "2024 Notes") held by the Reporting Persons for (i) a cash payment of $200 million plus accrued and unpaid interest on the reported securities through, and including, August 26, 2021 and (ii) 310,394 shares of common stock of the Issuer, par value $0.001 per share ("Common Stock"), which share amount was calculated using a 20-day volume weighted average price ending on, and including, August 26, 2021.

F1 · shares: Reflects an exchange of $150 million aggregate principal amount of the Issuer's 3.50% Convertible Senior Notes due October 1, 2024 (the "2024 Notes") held by the Reporting Persons for (i) a cash payment of $200 million plus accrued and unpaid interest on the reported securities through, and including, August 26, 2021 and (ii) 310,394 shares of common stock of the Issuer, par value $0.001 per share ("Common Stock"), which share amount was calculated using a 20-day volume weighted average price ending on, and including, August 26, 2021.

F5 · derivative.exercise_date: The reported securities were convertible at any time prior to the close of business on the scheduled trading day immediately preceding October 1, 2024, subject to earlier conversion or redemption in accordance with their terms.

F5 · derivative.expiration_date: The reported securities were convertible at any time prior to the close of business on the scheduled trading day immediately preceding October 1, 2024, subject to earlier conversion or redemption in accordance with their terms.

F2 · derivative.underlying_shares: Under the terms of the 2024 Notes, upon conversion of the 2024 Notes, the Issuer was required to deliver, at the Issuer's election, cash, shares of Common Stock, or a combination of cash and shares of Common Stock. The 2024 Notes had an initial conversion rate of 13.3333 shares of Common Stock per $1,000 principal amount of the 2024 Notes, which was the equivalent of an initial conversion price of approximately $75 per share of Common Stock. The initial conversion rate was subject to adjustment from time to time in accordance with the terms of an indenture, dated as of October 4, 2018, by and between the Issuer and Citibank, N.A., as trustee.

F3 · ownership.nature: Orogen Echo LLC ("OE") directly owns the reported securities. The Orogen Group LLC ("Orogen") is the sole member of OE and Vikram S. Pandit ("Mr. Pandit") is the Chairman and Chief Executive Officer of Orogen and serves on the board of directors of ExlService Holdings, Inc. (the "Issuer"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of Orogen. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the Reporting Persons, other than Mr. Pandit, is acting as a director by deputization of the Issuer with respect to Mr. Pandit's membership on the board of directors of the Issuer. Each of the Reporting Persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-21-015509 · dp158133_4-orogen.xml · nonDerivative · entry 1

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 310,394

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects an exchange of $150 million aggregate principal amount of the Issuer's 3.50% Convertible Senior Notes due October 1, 2024 (the "2024 Notes") held by the Reporting Persons for (i) a cash payment of $200 million plus accrued and unpaid interest on the reported securities through, and including, August 26, 2021 and (ii) 310,394 shares of common stock of the Issuer, par value $0.001 per share ("Common Stock"), which share amount was calculated using a 20-day volume weighted average price ending on, and including, August 26, 2021.

F2 · price: Under the terms of the 2024 Notes, upon conversion of the 2024 Notes, the Issuer was required to deliver, at the Issuer's election, cash, shares of Common Stock, or a combination of cash and shares of Common Stock. The 2024 Notes had an initial conversion rate of 13.3333 shares of Common Stock per $1,000 principal amount of the 2024 Notes, which was the equivalent of an initial conversion price of approximately $75 per share of Common Stock. The initial conversion rate was subject to adjustment from time to time in accordance with the terms of an indenture, dated as of October 4, 2018, by and between the Issuer and Citibank, N.A., as trustee.

F3 · ownership.nature: Orogen Echo LLC ("OE") directly owns the reported securities. The Orogen Group LLC ("Orogen") is the sole member of OE and Vikram S. Pandit ("Mr. Pandit") is the Chairman and Chief Executive Officer of Orogen and serves on the board of directors of ExlService Holdings, Inc. (the "Issuer"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of Orogen. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the Reporting Persons, other than Mr. Pandit, is acting as a director by deputization of the Issuer with respect to Mr. Pandit's membership on the board of directors of the Issuer. Each of the Reporting Persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-21-009106 · dp152994_pandit.xml · derivative · entry 1

PANDIT VIKRAM S · CIK 0001183417 · Director

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Footnotes

Disclosed balance after: 6,778

Underlying: Common Stock, par value $0.001 per share · 1,420 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock upon settlement.

F2 · derivative.exercise_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F2 · derivative.expiration_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F3 · ownership.nature: Mr. Pandit serves on the Board and is the Chairman and Chief Executive Officer of Orogen Echo LLC ("OE"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC, which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-21-010075 · dp153969_4-pandit.xml · derivative · entry 1

PANDIT VIKRAM S · CIK 0001183417 · Director

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 6,778

Underlying: Common Stock, par value $0.001 per share · 1,420 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock upon settlement.

F2 · date: The reporting person previously reported the transaction set forth herein on a Form 4 filed on June 21, 2021. However, the Form 4 was inadvertently filed in relation to a different issuer.

F3 · derivative.exercise_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F3 · derivative.expiration_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F4 · ownership.nature: Mr. Pandit serves on the Board and is the Chairman and Chief Executive Officer of Orogen Echo LLC ("OE"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC, which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F5 · ownership.nature: Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-21-002219 · dp145411_4-orogen.xml · derivative · entry 4

Orogen Viper LLC · CIK 0001705498 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · SEE FOOTNOTE

Disclosed balance after: 0

Underlying: Common Stock · 1,066,542 shares

Expires 2024-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Vikram S. Pandit ("Mr. Pandit") is the Chairman and Chief Executive Officer of OV, which directly owned the Convertible Preferred and therefore became the direct owner of the underlying Common Stock of the Issuer that were acquired upon conversion of the Convertible Preferred. The Orogen Group LLC ("Orogen") is the sole member of OV and Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members of Orogen and jointly control the investment decisions of Orogen. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis ("Mr. Angelakis") is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F2 · ownership.nature: Vikram S. Pandit ("Mr. Pandit") is the Chairman and Chief Executive Officer of OV, which directly owned the Convertible Preferred and therefore became the direct owner of the underlying Common Stock of the Issuer that were acquired upon conversion of the Convertible Preferred. The Orogen Group LLC ("Orogen") is the sole member of OV and Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members of Orogen and jointly control the investment decisions of Orogen. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis ("Mr. Angelakis") is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F3 · ownership.nature: Because of an arrangement among the Reporting Persons with respect to the equity grants received by Mr. Pandit in his capacity as a director of the Issuer, each Reporting Person may be deemed to have beneficial ownership of the reported securities, provided that each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0000950103-21-002219 · dp145411_4-orogen.xml · derivative · entry 3

Orogen Viper LLC · CIK 0001705498 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · SEE FOOTNOTE

Disclosed balance after: 0

Underlying: Common Stock · 1,964,684 shares

Expires 2024-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Vikram S. Pandit ("Mr. Pandit") is the Chairman and Chief Executive Officer of OV, which directly owned the Convertible Preferred and therefore became the direct owner of the underlying Common Stock of the Issuer that were acquired upon conversion of the Convertible Preferred. The Orogen Group LLC ("Orogen") is the sole member of OV and Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members of Orogen and jointly control the investment decisions of Orogen. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis ("Mr. Angelakis") is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F2 · ownership.nature: Vikram S. Pandit ("Mr. Pandit") is the Chairman and Chief Executive Officer of OV, which directly owned the Convertible Preferred and therefore became the direct owner of the underlying Common Stock of the Issuer that were acquired upon conversion of the Convertible Preferred. The Orogen Group LLC ("Orogen") is the sole member of OV and Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members of Orogen and jointly control the investment decisions of Orogen. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis ("Mr. Angelakis") is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F3 · ownership.nature: Because of an arrangement among the Reporting Persons with respect to the equity grants received by Mr. Pandit in his capacity as a director of the Issuer, each Reporting Person may be deemed to have beneficial ownership of the reported securities, provided that each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0000950103-21-002219 · dp145411_4-orogen.xml · nonDerivative · entry 2

Orogen Viper LLC · CIK 0001705498 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

F4 · balance_after: On February 11, 2021, pursuant to the terms of the Merger Agreement, dated as of September 9, 2020, by and among Austin HoldCo Inc., a Delaware corporation (that is owned by Baring Private Equity Asia), Austin BidCo Inc., a Delaware corporation and a wholly owned subsidiary of Parent and the Issuer, the Reporting Persons' equity interests in the Issuer were canceled and thus delivered back to the Issuer, and converted into the right to receive $51.35 in cash and the Reporting Persons disposed of all of their equity securities in the Issuer in connection with the completion of the transactions contemplated by the Merger Agreement.

F2 · ownership.nature: Vikram S. Pandit ("Mr. Pandit") is the Chairman and Chief Executive Officer of OV, which directly owned the Convertible Preferred and therefore became the direct owner of the underlying Common Stock of the Issuer that were acquired upon conversion of the Convertible Preferred. The Orogen Group LLC ("Orogen") is the sole member of OV and Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members of Orogen and jointly control the investment decisions of Orogen. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis ("Mr. Angelakis") is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F3 · ownership.nature: Because of an arrangement among the Reporting Persons with respect to the equity grants received by Mr. Pandit in his capacity as a director of the Issuer, each Reporting Person may be deemed to have beneficial ownership of the reported securities, provided that each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0000950103-21-002219 · dp145411_4-orogen.xml · nonDerivative · entry 1

Orogen Viper LLC · CIK 0001705498 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 3,045,856

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The reported securities include (i) 3,031,226 shares of common stock ("Common Stock") of Virtusa Corporation (the "Issuer") acquired upon the conversion of the 70,000 shares of the Issuer's 3.875% Series A Convertible Preferred Stock and 38,000 shares of the Issuer's 3.875% Series A-1 Convertible Preferred Stock (together, the "Convertible Preferred") that were directly owned by Orogen Viper LLC ("OV") and (ii) 14,630 shares of Issuer common stock in respect of grants of restricted stock units granted under the Issuer's Fourth Amended and Restated Director Compensation Policy (or its applicable predecessors) and 2015 Stock Option and Incentive Plan.

F2 · ownership.nature: Vikram S. Pandit ("Mr. Pandit") is the Chairman and Chief Executive Officer of OV, which directly owned the Convertible Preferred and therefore became the direct owner of the underlying Common Stock of the Issuer that were acquired upon conversion of the Convertible Preferred. The Orogen Group LLC ("Orogen") is the sole member of OV and Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members of Orogen and jointly control the investment decisions of Orogen. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis ("Mr. Angelakis") is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F3 · ownership.nature: Because of an arrangement among the Reporting Persons with respect to the equity grants received by Mr. Pandit in his capacity as a director of the Issuer, each Reporting Person may be deemed to have beneficial ownership of the reported securities, provided that each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0000950103-20-024353 · dp143059_4-orogen.xml · nonDerivative · entry 1

Orogen Viper LLC · CIK 0001705498 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 14,630

F1 · shares: In his capacity as a director of Virtusa Corporation (the "Issuer"), Vikram S. Pandit ("Mr. Pandit"), was granted under the Issuer's Fourth Amended and Restated Director Compensation Policy and 2015 Stock Option and Incentive Plan 2,784 shares of restricted stock units of the Issuer which will vest 33.33% on each of 9/1/2021, 9/1/2022 and 9/1/2023, subject to Mr. Pandit's continued service as a director of the Issuer through the applicable vesting date.

F2 · balance_after: The reported securities do not include 108,000 shares of the Issuer's 3.875% Series A Convertible Preferred Stock (the "Convertible Preferred"), which are convertible by the holders thereof, at their option, at any time before May 3, 2024, into shares of the Issuer's common stock (the "Common Stock"), and which, as reported on the Initial Statement of Beneficial Ownership of Securities on Form 3, as filed by the Reporting Persons on May 5, 2017, are collectively convertible at an initial conversion rate of 27.77778 shares of Common Stock per share of Convertible Preferred, into 3,000,000 shares of Common Stock.

F3 · ownership.nature: Mr. Pandit is the Chairman and Chief Executive Officer of Orogen Viper LLC ("OV"), which directly owns the Convertible Preferred and therefore beneficially owns the underlying Common Stock of the Issuer that can be acquired upon conversion of the Convertible Preferred. Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members jointly control the investment decisions of The Orogen Group LLC ("Orogen"), which is the sole member of OV. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Because of an arrangement among the Reporting Persons with respect to the equity grants received by Mr. Pandit in his capacity as a director of the Issuer, each Reporting Person may be deemed to have beneficial ownership of the reported securities, provided that each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0000950103-20-011909 · dp130522_4-pandit.xml · derivative · entry 1

PANDIT VIKRAM S · CIK 0001183417 · Director

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 5,358

Underlying: Common Stock, par value $0.001 per share · 2,363 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock ("Common Stock") of ExlService Holdings, Inc. (the "Issuer") upon settlement.

F2 · derivative.exercise_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the Issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F2 · derivative.expiration_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the Issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F3 · ownership.nature: Mr. Pandit serves on the Board and is the Chairman and Chief Executive Officer of Orogen Echo LLC ("OE"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC ("Orogen"), which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the Issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-19-012505 · dp112968_4-orogen.xml · nonDerivative · entry 1

Orogen Viper LLC · CIK 0001705498 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 11,846

F1 · shares: In his capacity as a director of Virtusa Corporation (the "Issuer"), Vikram S. Pandit ("Mr. Pandit"), was granted under the Issuer's Fourth Amended and Restated Director Compensation Policy and 2015 Stock Option and Incentive Plan 3,558 shares of restricted stock units of the Issuer which will vest 33.33% on each of 9/1/2020, 9/1/2021 and 9/1/2022, subject to Mr. Pandit's continued service as a director of the Issuer through the applicable vesting date.

F2 · balance_after: The reported securities do not include 108,000 shares of the Issuer's 3.875% Series A Convertible Preferred Stock (the "Convertible Preferred"), which are convertible by the holders thereof, at their option, at any time before May 3, 2024, into shares of the Issuer's common stock (the "Common Stock"), and which, as reported on the Initial Statement of Beneficial Ownership of Securities on Form 3, as filed by the Reporting Persons on May 5, 2017, are collectively convertible at an initial conversion rate of 27.77778 shares of Common Stock per share of Convertible Preferred, into 3,000,000 shares of Common Stock.

F3 · ownership.nature: Mr. Pandit is the Chairman and Chief Executive Officer of Orogen Viper LLC ("OV"), which directly owns the Convertible Preferred and therefore beneficially owns the underlying Common Stock of the Issuer that can be acquired upon conversion of the Convertible Preferred. Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members jointly control the investment decisions of The Orogen Group LLC ("Orogen"), which is the sole member of OV. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Because of an arrangement among the Reporting Persons with respect to the equity grants received by Mr. Pandit in his capacity as a director of the Issuer, each Reporting Person may be deemed to have beneficial ownership of the reported securities, provided that each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0000950103-19-008214 · dp108604_4-pandit.xml · derivative · entry 1

PANDIT VIKRAM S · CIK 0001183417 · Director

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,995

Underlying: Common Stock, par value $0.001 per share · 1,796 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock ("Common Stock") of ExlService Holdings, Inc. (the "Issuer") upon settlement.

F2 · derivative.exercise_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the Issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F2 · derivative.expiration_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the Issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F3 · ownership.nature: Mr. Pandit serves on the Board and is the Chairman and Chief Executive Officer of Orogen Echo LLC ("OE"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC ("Orogen"), which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the Issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-18-011818 · ownership.xml · derivative · entry 1

PANDIT VIKRAM S · CIK 0001183417 · Director

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,199

Underlying: Common Stock, par value $0.001 per share · 1,199 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock ("Common Stock") of ExlService Holdings, Inc. (the "Issuer") upon settlement.

F2 · derivative.exercise_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the Issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F2 · derivative.expiration_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the Issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F3 · ownership.nature: Mr. Pandit serves on the Board and is the Chairman and Chief Executive Officer of Orogen Echo LLC ("OE"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC ("Orogen"), which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the Issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-18-010702 · dp95598_4-orogen.xml · nonDerivative · entry 1

Orogen Viper LLC · CIK 0001705498 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 8,288

F1 · shares: In his capacity as a director of Virtusa Corporation (the "Issuer"), Vikram S. Pandit ("Mr. Pandit"), was granted under the Issuer's Fourth Amended and Restated Director Compensation Policy and 2015 Stock Option and Incentive Plan 2,467 shares of restricted stock units of the Issuer which will vest 33.33% on each of 9/1/2019, 9/1/2020 and 9/1/2021, subject to Mr. Pandit's continued service as a director of the Issuer through the applicable vesting date.

F2 · balance_after: The reported securities do not include 108,000 shares of the Issuer's 3.875% Series A Convertible Preferred Stock (the "Convertible Preferred"), which are convertible by the holders thereof, at their option, at any time before May 3, 2024, into shares of the Issuer's common stock (the "Common Stock"), and which, as reported on the Initial Statement of Beneficial Ownership of Securities on Form 3, as filed by the Reporting Persons on May 5, 2017, are collectively convertible at an initial conversion rate of 27.77778 shares of Common Stock per share of Convertible Preferred, into 3,000,000 shares of Common Stock.

F3 · ownership.nature: Mr. Pandit is the Chairman and Chief Executive Officer of Orogen Viper LLC ("OV"), which directly owns the Convertible Preferred and therefore beneficially owns the underlying Common Stock of the Issuer that can be acquired upon conversion of the Convertible Preferred. Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members jointly control the investment decisions of The Orogen Group LLC ("Orogen"), which is the sole member of OV. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Because of an arrangement among the Reporting Persons with respect to the equity grants received by Mr. Pandit in his capacity as a director of the Issuer, each Reporting Person may be deemed to have beneficial ownership of the reported securities, provided that each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0000950103-17-012244 · dp83936_4-orogen.xml · nonDerivative · entry 1

Orogen Viper LLC · CIK 0001705498 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 5,821

F1 · shares: In his capacity as a director of Virtusa Corporation (the "Issuer"), Vikram S. Pandit ("Mr. Pandit"), was granted under the Issuer's Fourth Amended and Restated Director Compensation Policy and 2015 Stock Option and Incentive Plan 3,094 shares of restricted stock units of the Issuer which will vest 33.33% on each of 9/1/2018, 9/1/2019 and 9/1/2020, subject to Mr. Pandit's continued service as a director of the Issuer through the applicable vesting date.

F2 · balance_after: The reported securities do not include 108,000 shares of the Issuer's 3.875% Series A Convertible Preferred Stock (the "Convertible Preferred"), which are convertible by the holders thereof, at their option, at any time before May 3, 2024, into shares of the Issuer's common stock (the "Common Stock"), and which, as reported on the Initial Statement of Beneficial Ownership of Securities on Form 3, as filed by the Reporting Persons on May 5, 2017, are collectively convertible at an initial conversion rate of 27.77778 shares of Common Stock per share of Convertible Preferred, into 3,000,000 shares of Common Stock.

F3 · ownership.nature: Mr. Pandit is the Chairman and Chief Executive Officer of Orogen Viper LLC ("OV"), which directly owns the Convertible Preferred and therefore beneficially owns the underlying Common Stock of the Issuer that can be acquired upon conversion of the Convertible Preferred. Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members jointly control the investment decisions of The Orogen Group LLC ("Orogen"), which is the sole member of OV. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Because of an arrangement among the Reporting Persons with respect to the equity grants received by Mr. Pandit in his capacity as a director of the Issuer, each Reporting Person may be deemed to have beneficial ownership of the reported securities, provided that each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0000950103-17-004366 · dp75928_4-orogen.xml · nonDerivative · entry 2

Orogen Viper LLC · CIK 0001705498 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 2,727

F1 · shares: In his capacity as a director of Virtusa Corporation (the "Issuer"), Vikram S. Pandit ("Mr. Pandit"), was granted under the Issuer's Amended and Restated Director Compensation Policy and 2015 Stock Option and Incentive Plan (i) 1,636 shares of restricted stock units of the Issuer which will vest 33.33% on each of 6/1/18, 6/1/19 and 6/1/20, and (ii) 1,091 restricted stock units of the Issuer which will vest 33.33% on each of 9/1/17, 9/1/18 and 9/1/19, in each case subject to Mr. Pandit's continued service as a director of the Issuer through the applicable vesting date.

F2 · balance_after: The reported securities do not include 70,000 shares of the Issuer's 3.875% Series A Convertible Preferred Stock or 38,000 shares of the Issuer's 3.875% Series A-1 Convertible Preferred Stock (together, the "Convertible Preferred"), which are convertible by the holders thereof, at their option, at any time before May 3, 2024, into shares of the Issuer's common stock ("Common Stock"), and which, as reported on the Initial Statement of Beneficial Ownership of Securities on Form 3, as filed by the Reporting Persons on May 5, 2017, are collectively convertible at an initial conversion rate of 27.77778 shares of Common Stock per share of Preferred Stock, into 3,000,000 shares of Common Stock.

F3 · ownership.nature: Mr. Pandit is the Chairman and Chief Executive Officer of Orogen Viper LLC ("OV"), which directly owns the Convertible Preferred and therefore beneficially owns the underlying Common Stock of the Issuer that can be acquired upon conversion of the Convertible Preferred. Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members jointly control the investment decisions of The Orogen Group LLC ("Orogen"), which is the sole member of OV. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Because of an arrangement among the Reporting Persons with respect to the equity grants received by Mr. Pandit in his capacity as a director of the Issuer, each Reporting Person may be deemed to have beneficial ownership of the reported securities, provided that each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0000950103-17-004366 · dp75928_4-orogen.xml · nonDerivative · entry 1

Orogen Viper LLC · CIK 0001705498 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,636

F1 · shares: In his capacity as a director of Virtusa Corporation (the "Issuer"), Vikram S. Pandit ("Mr. Pandit"), was granted under the Issuer's Amended and Restated Director Compensation Policy and 2015 Stock Option and Incentive Plan (i) 1,636 shares of restricted stock units of the Issuer which will vest 33.33% on each of 6/1/18, 6/1/19 and 6/1/20, and (ii) 1,091 restricted stock units of the Issuer which will vest 33.33% on each of 9/1/17, 9/1/18 and 9/1/19, in each case subject to Mr. Pandit's continued service as a director of the Issuer through the applicable vesting date.

F2 · balance_after: The reported securities do not include 70,000 shares of the Issuer's 3.875% Series A Convertible Preferred Stock or 38,000 shares of the Issuer's 3.875% Series A-1 Convertible Preferred Stock (together, the "Convertible Preferred"), which are convertible by the holders thereof, at their option, at any time before May 3, 2024, into shares of the Issuer's common stock ("Common Stock"), and which, as reported on the Initial Statement of Beneficial Ownership of Securities on Form 3, as filed by the Reporting Persons on May 5, 2017, are collectively convertible at an initial conversion rate of 27.77778 shares of Common Stock per share of Preferred Stock, into 3,000,000 shares of Common Stock.

F3 · ownership.nature: Mr. Pandit is the Chairman and Chief Executive Officer of Orogen Viper LLC ("OV"), which directly owns the Convertible Preferred and therefore beneficially owns the underlying Common Stock of the Issuer that can be acquired upon conversion of the Convertible Preferred. Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members jointly control the investment decisions of The Orogen Group LLC ("Orogen"), which is the sole member of OV. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Because of an arrangement among the Reporting Persons with respect to the equity grants received by Mr. Pandit in his capacity as a director of the Issuer, each Reporting Person may be deemed to have beneficial ownership of the reported securities, provided that each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.